|
|
Cancer Market Research Reports
 | |  |
| |
Global Information, Inc. offers market intelligence on every topic in the Cancer Therapeutic/Diagnosis, including, but not limited to market trend on therapeutic of: Lung Cancer; Melanoma; Colorectal Cancer; Breast Cancer; Tumor; Cervical Cancer; Ovarian Cancer; Myeloma; Pancreatic Cancer and new Anticancer therapeutic like Immunotherapies; Angiogenesis Inhibitors; Protein Kinase Inhibitors.
We offer market research, industry forecasts, and business analysis in the Cancer Therapeutic/Diagnosis as well as other vertical industries. GII sells reports, databases, newsletters and annual information services that provide the latest market data, such as industry forecasts, projections, trends, market shares, research and development, sales and marketing strategies, and competitive analysis. The easiest way to find out if we have the information you need is to contact us right now. We are open 24 hours a day, 5 days a week with multiple language support. Please see our Contact page to see which office is open right now.
|
|
 | |  |
| Drug Delivery in Cancer - technologies, markets and companies |
|
| Table of Contents Published: 2009/11 Published by: Jain Pharmabiotech |
| Drug delivery remains a challenge in management of cancer. Approximately 12.5 million new cases of cancer are being diagnosed worldwide each year and considerable research is in progress for drug discovery for cancer. Cancer drug delivery is no longer sim ... |
| Global Skin Cancer Therapeutics Markets |
|
| Table of Contents Published: 2009/10 Published by: Frost & Sullivan |
| This research service analyses the global skin cancer therapeutics market. It analyses market drivers, restraints and challenges faced by industry participants. Revenue forecasts and pipeline analysis has been discussed. It also provides strategic recomme ... |
| Chinese Markets for Anti-Tumor Drugs |
|
| Table of Contents Published: 2009/09 Published by: Asia Market Information & Development Co. |
| China' s demand for Anti-Tumor Drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China' s economic trends, investment environment, industry development, sup ... |
| Chinese Markets for Bladder Cancer Treatment |
|
| Table of Contents Published: 2009/09 Published by: Asia Market Information & Development Co. |
| China' s demand for Bladder Cancer Treatment Drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China' s economic trends, investment environment, industry de ... |
| Chinese Markets for Brain Cancer Treatment Drugs |
|
| Table of Contents Published: 2009/09 Published by: Asia Market Information & Development Co. |
| China' s demand for Brain Cancer Treatment Drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China' s economic trends, investment environment, industry deve ... |
| Chinese Markets for Cervical Cancer Treatment Drugs |
|
| Table of Contents Published: 2009/09 Published by: Asia Market Information & Development Co. |
| China' s demand for Cervical Cancer Treatment Drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China' s economic trends, investment environment, industry d ... |
| Chinese Markets for Colon Cancer Treatment Drugs |
|
| Table of Contents Published: 2009/09 Published by: Asia Market Information & Development Co. |
| China' s demand for Colon Cancer Treatment Drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China' s economic trends, investment environment, industry deve ... |
| Competitive Outlook on Lung Cancer Drug Development |
|
| Table of Contents Published: 2009/08 Published by: BioSeeker Group AB |
| This report includes defined and up to date development strategies for 283 lung cancer therapeutic drugs (>317 projects) within the portfolio of 167 investigators, from Ceased to Marketed. In total the report assesses three different sub-indications of lu ... |
| Molecular Targeted Cancer Therapies Market Forecast |
|
| Table of Contents Published: 2009/08 Published by: Datamonitor |
| Molecular targeted cancer therapies are the biggest and fastest growing class of cancer drugs in terms of sales. As growth of revenues from cytotoxic therapies and antihormonal therapies has slowed and many key brands in these classes face imminent patent ... |
| Antihormonal Therapies Market Forecast |
|
| Table of Contents Published: 2009/07 Published by: Datamonitor |
| Antihormonal cancer therapies are a class of drugs used predominantly in the treatment of breast cancer and prostate cancer. The high incidence of these tumor types translates into a significant commercial potential for drug developers. Collectively, the ... |
| Brachytherapy |
|
| Table of Contents Published: 2009/07 Published by: Global Industry Analysts, Inc. |
| This report analyzes the Global Market for Brachytherapy in Millions of US$. The eBrachytherapy' market is analyzed in terms of the following product segments: Implantable Prostate Seeds Brachytherapy, and Post-Operative Brachytherapy. Annual forecasts a ... |
| Competitor Analysis: HDAC Inhibitors |
|
| Table of Contents Published: 2009/07 Published by: La Merie |
| The present Competitive Intelligence Report about HDAC Inhibitors provides a competitor evaluation in the field of novel molecular entities inhibiting histone deacetylase for treatment of cancer and other diseases as of July 2009. ... |
| Competitor Analysis: PI3K-AKT-mTOR Inhibitors |
|
| Published: 2009/07 Published by: La Merie |
| The report includes a compilation of current active projects in research and development of PI3K-AKT-mTOR inhibitors in oncology and other indications. ... |
| Lung Cancer Therapeutics |
|
| Table of Contents Published: 2009/07 Published by: Global Industry Analysts, Inc. |
| This report analyzes the worldwide markets (Annual Revenues) for Lung Cancer Therapeutics in Millions of US$. The US market for Non-Small Cell Lung Cancer treatment is further analyzed by: Chemotherapy Drugs, and Targeted Drugs. ... |
| Chinese Markets for Leukemia Treatment Drugs |
|
| Table of Contents Published: 2009/06 Published by: Asia Market Information & Development Co. |
| China' s demand for Leukemia Treatment Drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China' s economic trends, investment environment, industry developm ... |
| Cytotoxic Therapies Market Forecast |
|
| Table of Contents Published: 2009/06 Published by: Datamonitor |
| The cytotoxics market is mature and characterized by an increasing level of genericization. Several blockbuster products will undergo patent expiry during the forecast period, however, by virtue of these drugs' success, generic entry will ensure continued ... |
| Oncology Partnering Agreements in Pharma, Biotech and Diagnostics |
|
| Table of Contents Published: 2009/06 Published by: CurrentPartnering, a division of Wildwood Ventures Limited |
| The Oncology Partnering Agreements in Pharma, Biotech and Diagnostics report provides comprehensive understanding and unprecedented access to the oncology partnering agreements entered into by the worlds leading biopharma companies.
The report provide ... |
| Monoclonal Antibodies in Cancer Therapy 2009-2024 |
|
| Table of Contents Published: 2009/05 Published by: Visiongain |
| Monoclonal antibody-based therapies for cancer are a thriving part of the biotechnology sector, as our new market report explains. The oncology market continues to expand worldwide, with high demand for more-efficacious and better-tolerated cancer therapi ... |
| Chinese Markets for Lymphoma Treatment Drugs |
|
| Table of Contents Published: 2009/04 Published by: Asia Market Information & Development Co. |
| China' s demand for Lymphoma Treatment Drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China' s economic trends, investment environment, industry developm ... |
| Chinese Markets for Ovarian Cancer Treatment Drugs |
|
| Table of Contents Published: 2009/04 Published by: Asia Market Information & Development Co. |
| China' s demand for Ovarian Cancer Treatment Drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China' s economic trends, investment environment, industry de ... |
| Multiple Myeloma Therapeutics |
|
| Table of Contents Published: 2009/04 Published by: Global Industry Analysts, Inc. |
| This report analyzes the US market for Multiple Myeloma Therapeutics in Millions of US$. TThe market for multiple myeloma therapeutics is analyzed by the following Drugs: Thalomid, Revlimid, Velcade, and Others. The market for multiple myeloma therapeutic ... |
| Prostate Cancer Therapeutics |
|
| Table of Contents Published: 2009/04 Published by: Global Industry Analysts, Inc. |
| This report analyzes the worldwide markets for Prostate Cancer Therapeutics in US$ Millions. Analytics in the report specifically focuses on revenues generated from hormonal therapies.The report provides separate comprehensive analytics for US, Europe, an ... |
| Stakeholder Opinions: Gastric Cancer - Targeted therapies compete for first-to-market status |
|
| Table of Contents Published: 2009/04 Published by: Datamonitor |
| Gastric cancer incidence in 2009 is forecast to be 197,000 in the seven major pharmaceutical markets (US, Japan, Germany, France, Italy, Spain, and UK). Although, the global incidence has decreased in recent years, mortality remains high, particularly in ... |
| Lung Cancer Drug Discoveries: what the future holds |
|
| Table of Contents Published: 2009/03 Published by: Espicom Business Intelligence |
| Although a plethora of platinum-based chemotherapy combinations may be prescribed for the treatment of non-small cell lung cancer (NSCLC), the market is currently driven by chemotherapeutic agents such as the taxanes and antimetabolites, and the increasin ... |
| Target Atlas in Oncology Drug Development: Major Tumor Types |
|
| Published: 2009/03 Published by: BioSeeker Group AB |
| With the emergence of new technologies and an increased understanding of the biological basis for cancer evolution, the molecular changes that distinguish malignant-cells from normal cells are becoming increasingly apparent, offering a growing range of po ... |
| Target Atlas in Oncology Drug Development: Targeted Therapies |
|
| Table of Contents Published: 2009/03 Published by: BioSeeker Group AB |
| With the emergence of new technologies and an increased understanding of the biological basis for cancer evolution, the molecular changes that distinguish malignant-cells from normal cells are becoming increasingly apparent, offering a growing range of po ... |
| Triple Target Atlas in Oncology Drug Development |
|
| Published: 2009/03 Published by: BioSeeker Group AB |
| With the emergence of new technologies and an increased understanding of the biological basis for cancer evolution, the molecular changes that distinguish malignant-cells from normal cells are becoming increasingly apparent, offering a growing range of po ... |
| Apoptosis 2009: Opportunities in Cancer and Other Diseases |
|
| Table of Contents Published: 2009/02 Published by: Biophoenix Limited |
| Apoptosis is regarded as the major mode of cell death in cancer and should therefore be considered as a potential target when developing new antineoplastic drugs. An increasing number of companies are doing so, and we anticipate that this approach will pa ... |
| Cancer Pain |
|
| Table of Contents Published: 2009/02 Published by: WWMR, Inc. |
| In this report WWMR, Inc., provides an overview of cancer pain in the US market.
This report also summarizes WWMR, Inc.' s current understanding of cancer pain mechanisms, and highlights promising targets for drug development. Also reviewed are new tr ... |
|
| Cancer Analysis |
|
| Published by: Espicom Business Intelligence |
| Cancer Intelligence Online is a new, daily-updated online business resource from Espicom. No other business intelligence service provides such current and extensive content. A subscription to Cancer Intelligence Online will save hours of research and make ... |
|
| Cancer Drug News |
|
| Issues / Year: 44 Published by: Espicom Business Intelligence |
| Cancer Drug News (CDN) can save you the time and effort of ensuring you have the necessary information to keep up-to-date with the developments in this world market. ... |
|
|
|
View Cart
